RxDoctor Payments Data

Neil Goodman, DO

Family Medicine · Big Rapids, MINPI 1992720684

Payments from drug & device makers

$1,252in general payments, 2019–2025

Across 72 payments — averaging $17.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$282
  • Novo Nordisk$176
  • Pfizer$144
  • GSK$114
  • Dexcom, Inc.$109
  • Novartis$60
  • plus $366 from 16 others

What the payments were for

  • Food & beverage$1,21497%
  • Education$383%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,252 in reported general payments places this provider in the 75th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$152,813
Medicare patients
449
Services billed
2,594

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban214$235,158
JardianceEmpagliflozin150$217,816
Trelegy ElliptaFluticasone/Umeclidin/Vilanter87$94,557
JanuviaSitagliptin Phosphate64$57,398
XareltoRivaroxaban48$56,024
FarxigaDapagliflozin Propanediol44$51,338
TrulicityDulaglutide21$24,339
OzempicSemaglutide11$21,422
EntrestoSacubitril/Valsartan13$20,616
Lantus SolostarInsulin Glargine,hum.Rec.Anlog87$16,043
MyrbetriqMirabegron24$15,662
Atorvastatin Calcium867$14,531
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr16$13,974
Spiriva RespimatTiotropium Bromide14$13,869
CreonLipase/Protease/Amylase24$13,660

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Spiriva Respimat, Tradjenta$38$237,300176 claims
PfizerEliquis$144$235,158214 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$114$115,673114 claims
AstraZenecaFarxiga, Symbicort$46$59,77373 claims
Novo NordiskOzempic$176$21,42211 claims
NovartisEntresto$60$20,61613 claims
Astellas Pharma US IncMyrbetriq$49$15,66224 claims
AbbVieCreon$282$13,66024 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Big Rapids

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →